The Online Books Page

Drugs -- Purchasing -- United States

See also what's at your library, or elsewhere.

• Drugs -- Purchasing
• Medical supplies -- Purchasing -- United States
• Drugs -- United States
• Purchasing -- United States

• Drugs -- United States -- Purchasing

• Drugs -- Purchasing -- United States -- Cost control
• Drugs -- Purchasing -- United States -- Records and correspondence
• Drugs -- Purchasing -- Government policy -- United States

• Importation of prescription drugs : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Eighth Congress, second session, on examining prescription drug reimportation, focusing on efforts to reduce drug costs, patient safety concerns, recent state action, fraudulent and counterfeit drugs, an international comparison of rising prescription drug expenditures, and S. 2328, to amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs, May 20, 2004. (U.S. G.P.O. :, 2005), by United States Senate Committee on Health, Education, Labor, and Pensions (page images at HathiTrust)
• Realities of safety and security regarding drug importation (U.S. G.P.O. :, 2005), by United States Senate Committee on Health, Education, Labor, and Pensions (page images at HathiTrust)
• Drug importation : would the price be right? : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session, on examining the price of drug reimportation, focusing on implications for United States consumers, pricing, research and development, and innovation, February 17, 2005. (U.S. G.P.O. :, 2005), by United States Senate Committee on Health, Education, Labor, and Pensions (page images at HathiTrust)
• Policy implications of pharmaceutical importation for U.S. consumers : hearing before the Subcommittee on Interstate Commerce, Trade, and Tourism of the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred Tenth Congress, first session, March 7, 2007. (U.S. G.P.O. :, 2013), by Science United States. Congress. Senate. Committee on Commerce (page images at HathiTrust)

• Department of Veterans Affairs prescription drug purchasing program (U.S. G.P.O. :, 2003), by Veterans Affairs United States. Congress. House. Committee on Government Reform. Subcommittee on National Security (page images at HathiTrust)

• An Act to Facilitate the Creation of Methamphetamine Precursor Electronic Logbook Systems, and for Other Purposes. (U.S. G.P.O. :, 2008), by United States (page images at HathiTrust)

• The Food and Drug Import Safety Act : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, on H.R. 3610, September 26, 2007. (U.S. G.P.O. :, 2008), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health (page images at HathiTrust)

Items below (if any) are from related and broader terms.

• Joint procurement of pharmaceuticals by VA and DOD : hearing before the Subcommittee Oversight and Investigations of the Committee on Veterans' Affairs, House of Representatives, One Hundred Sixth Congress, second session, May 25, 2000. (U.S. G.P.O. :, 2001), by United States. Congress. House. Committee on Veterans' Affairs. Subcommittee on Oversight and Investigations (page images at HathiTrust)

• Veterans Health Care and Procurement Improvement Act of 2002 : report (to accompany H.R. 3645) (including cost estimate of the Congressional Budget Office). (U.S. G.P.O., 2002), by United States House Committee on Veterans' Affairs (page images at HathiTrust)

• Veterans Health Administration contracting and procurement practices : hearing before the Subcommittee on Health of the Committee on Veterans' Affairs, U.S. House of Representatives, One Hundred Eleventh Congress, second session, September 23, 2010 (U.S. G.P.O. :, 2011), by United States. Congress. House. Committee on Veterans' Affairs. Subcommittee on Health (page images at HathiTrust)

• Competitive bidding for durable medical equipment, will small suppliers be able to compete (U.S. G.P.O. :, 2007), by United States. Congress. House. Committee on Small Business. Subcommittee on Investigations and Oversight (page images at HathiTrust)
• Competitive bidding for durable medical equipment (U.S. G.P.O. :, 2008), by United States. Congress. House. Committee on Small Business. Subcommittee on Rural and Urban Entrepreneurship (page images at HathiTrust)
• Impact of competitive bidding on small businesses in the durable medical equipment community (U.S. G.P.O. :, 2009), by Entrepreneurship United States. Congress. House. Committee on Small Business. Subcommittee on Rural Development (page images at HathiTrust)
• Medicare's DMEPOS Competitive Bidding Program : hearing before the Subcommittee on Health of the Committee on Ways and Means, U.S. House of Representatives, One Hundred Tenth Congress, second session, May 6, 2008. (U.S. G.P.O. :, 2009), by United States. Congress. House. Committee on Ways and Means. Subcommittee on Health (page images at HathiTrust)

• Medicare's DMEPOS Competitive Bidding Program : hearing before the Subcommittee on Health of the Committee on Ways and Means, U.S. House of Representatives, One Hundred Tenth Congress, second session, May 6, 2008. (U.S. G.P.O. :, 2009), by United States. Congress. House. Committee on Ways and Means. Subcommittee on Health (page images at HathiTrust)

• Drugs in perspective (National Institute on Drug Abuse, Division of Resource Development, Manpower and Training Branch :, 1979), by National Institute on Drug Abuse. Manpower and Training Branch, Lonnie E. Mitchell, William E. Link, and National Drug Abuse Center (U.S.) (page images at HathiTrust)
• Drugs in travelers' kit. (Center for Disease Control, 1986), by Centers for Disease Control (U.S.) (page images at HathiTrust)
• Guideline for the format and content of the summary for new drug and antibiotic applications. (Center for Drugs and Biologics, Food and Drug Administration, Dept. of Health and Human Services, 1987), by Center for Drugs and Biologics (U.S.) (page images at HathiTrust)
• Guideline on formatting, assembling, and submitting new drug and antibiotic applications. (Center for Drugs and Biologics, Food and Drug Administration, Dept. of Health and Human Services, 1987), by Center for Drugs and Biologics (U.S.) (page images at HathiTrust)
• Guideline for submitting supporting documentation in drug applications for the manufacture of drug substances (U.S. Dept. of Health and Human Services, Public Health Service, Food and Drug Administration, 1987), by Center for Drugs and Biologics (U.S.) (page images at HathiTrust)
• Guideline for submitting documentation for the manufacture of and controls for drug products. (Center for Drugs and Biologics, Food and Drug Administration, Dept. of Health and Human Services, 1987), by Center for Drugs and Biologics (U.S.) (page images at HathiTrust)
• Coverage of prescription drugs under Medicare hearing before the Subcommittee on Health of the Committee on Finance, United States Senate, One Hundredth Congress, first session, June 18, 1987. (U.S. G.P.O., 1988), by United States. Congress. Senate. Committee on Finance. Subcommittee on Health (page images at HathiTrust)
• The Food and Drug Administration's process for approving new drugs : report (U.S. G.P.O. :, 1980), by Research United States. Congress. House. Committee on Science and Technology. Subcommittee on Science (page images at HathiTrust)
• Funding implications of new combination therapies for federal and state programs (The Office, 1998), by United States General Accounting Office and Health and Human Services United States. Congress. Senate. Committee on Appropriations. Subcommittee on Departments of Labor (page images at HathiTrust)
• An FDA consumer memo. (Dept. of Health, Education, and Welfare, Public Health Service, Food and Drug Administration, Office of Public Affairs, 1979), by United States. Food and Drug Administration. Office of Public Affairs (page images at HathiTrust)
• Further investigation of look-alike drugs : hearing before the Select Committee on Narcotics Abuse and Control, House of Representatives, Ninety-seventh Congress, second session, August 12, 1982. (U.S. G.P.O., 1983), by United States. Congress. House. Select Committee on Narcotics Abuse and Control (page images at HathiTrust)
• Federal drug interdiction efforts need strong central oversight : report to the Congress (U.S. General Accounting Office ;, 1983), by United States General Accounting Office (page images at HathiTrust)
• Criminal penalty for robbery of controlled substances : hearing before the Subcommittee on Crime of the Committee on the Judiciary, House of Representatives, Ninety-eighth Congress, first session ... April 7, 1983. (U.S. G.P.O., 1984), by United States. Congress. House. Committee on the Judiciary. Subcommittee on Crime (page images at HathiTrust)
• Spectrophotometric determination of heroine and quinine ... (Govt. Print. Off.], 1955), by United States Internal Revenue Service (page images at HathiTrust)
• Drug regulation reform act of 1978. (U.S. Govt. Print. Off., 1978), by United States Department of Health, Education, and Welfare (page images at HathiTrust)
• Milestones in the war against the narcotic peril / extension of remarks of Walter F. Lineberger of California, in the House of Representatives, Wednesday, February 18, 1925. (G.P.O. ;, 1925), by Water Franklin Lineberger (page images at HathiTrust)
• Uniform narcotic drug act drafted by the National Conference of Commissioners on Uniform State Laws, and by it approved and recommended for enactment in all the states at its forty-second annual conference at Washington, D.C., October 4-10, 1932 ... ([Chicago], 1932), by National Conference of Commissioners on Uniform State Laws (page images at HathiTrust; US access only)
• Report on doctor-owned drug enterprises ... (U.S. Govt. Print. Off.?, 1966), by United States House Committee on the Judiciary and United States Food and Drug Administration (page images at HathiTrust)
• Guidelines for the time frame applicable to the review and approval of new drug applications and antibiotic applications. (Datapharm Information Services, Division of Interpharm Press, 1985), by Center for Drugs and Biologics (U.S.) and United States Food and Drug Administration (page images at HathiTrust)
• Guideline for submitting documentation for the stability of human drugs and biologics. (Datapharm Information Services, Division of Interpharm Press, 1987), by Center for Drugs and Biologics (U.S.) and United States Food and Drug Administration (page images at HathiTrust)

• Hair analysis as a drug detector (U.S. Dept. of Justice, Office of Justice Programs, National Institute of Justice, 1995), by Thomas Mieczkowski and National Institute of Justice (U.S.) (page images at HathiTrust)
• Hair assays and urinalysis results for juvenile drug offenders : a summary of research (U.S. Dept. of Justice, Office of Justice Programs, National Institute of Justice, 1997), by Thomas Mieczkowski and National Institute of Justice (U.S.) (page images at HathiTrust)

• HHS SSC Medical supply catalog (The Center, 1996), by Health and Human Services Supply Service Center (U.S.) (page images at HathiTrust)
• Drug list : pharmacy service (Richard L. Roudebush Medical Center, 1984), by United States. Veterans Administration and Richard L. Roudebush Medical Center (U.S.) (page images at HathiTrust)

• Drug registration and listing instruction booklet. (U.S. Dept. of Health and Human Services, Public Health Service, Food and Drug Administration, Center for Drug Evaluation and Research, Product Information Management Branch, 1996), by Center for Drug Evaluation and Research (U.S.). Product Information Management Branch (page images at HathiTrust)

• Final report (U.S. G.P.O. :, 1988), by White House Conference for a Drug Free America (page images at HathiTrust)

• Implications for beneficiaries of Medicare HMO use of formularies (The Office, 1999), by United States General Accounting Office and Medicare+Choice Program (U.S.) (page images at HathiTrust)
• FEHBP plans satisfied with savings and services, but retail pharmacies have concerns (The Office ;, 1997), by United States General Accounting Office (page images at HathiTrust)
• Greater Access to Affordable Pharmaceuticals Act (U.S. G.P.O. :, 2004), by United States Senate Committee on the Judiciary (page images at HathiTrust)
• Medicare reform (U.S. G.P.O. :, 2001), by United States. Congress. House. Committee on Ways and Means. Subcommittee on Health (page images at HathiTrust)

• Medical Technology and Costs of the Medicare Program (OTA-H-227; 1984), by United States Congress Office of Technology Assessment
  • page images at HathiTrust
  • PDF files with commentary at Princeton
  • PDF at unt.edu
• Medicaid : changes in drug prices paid by HMOs and hospitals since enactment of rebate provisions : report to Congressional committees (The Office ;, 1993), by United States General Accounting Office (page images at HathiTrust)
• Medicaid : changes in drug prices paid by VA and DOD since enactment of rebate provisions (The Office, 1991), by United States General Accounting Office (page images at HathiTrust)
• Beneficiary protections in Medicare Part D (U.S. G.P.O. :, 2009), by United States. Congress. House. Committee on Ways and Means. Subcommittee on Health (page images at HathiTrust)
• Prescribed medicines in ambulatory care settings : a comparison of use, expenditures, and sources of payment, 1977 and 1987 (The Agency, 1995), by John F. Moeller, Helen Levy, and Center for General Health Services Intramural Research (U.S.) (page images at HathiTrust)

• Drug regulation : FDA's computer systems need to be better managed : report to the Chairman, Subcommittee on Intergovernmental Relations and Human Resources, Committee on Government Operations, House of Representatives (The Office, 1986), by United States General Accounting Office (page images at HathiTrust)

More items available under broader and related terms at left.